We are live on ! Find out more
PROK icon

ProKidney
PROK

18 hedge funds and large institutions have $144M invested in ProKidney in 2022 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

23% less capital invested

Capital invested by funds: $187M → $144M (-$42.5M)

48.87% less ownership

Funds ownership: 74.91% → 26.04% (-49%)

73% less funds holding

Funds holding: 67 → 18 (-49)

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

80% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 60

Holders
18
Holders Change
-49
Holders Change %
-73.13%
% of All Funds
0.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
1
Reduced
4
Closed
60
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$90.1M
2
SCM
Suvretta Capital Management
New York
+$27.8M
3
BL
Bleichroeder LP
New York
+$17.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1.32M
5
BlackRock
BlackRock
New York
+$947K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$17.4M
2
Millennium Management
Millennium Management
New York
-$14.8M
3
ACA
Arena Capital Advisors
California
-$11.7M
4
SC
Sculptor Capital
New York
-$11.1M
5
FTCM
First Trust Capital Management
Illinois
-$8.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
1
Morgan Stanley
New York
$93.3M +$90.1M +10,351,656 New
SCM
2
Suvretta Capital Management
New York
$28.8M +$27.8M +3,193,175 New
BL
3
Bleichroeder LP
New York
$18M +$17.4M +2,000,000 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$1.37M +$1.32M +152,100 New
BlackRock
5
BlackRock
New York
$980K +$947K +108,802 New
Geode Capital Management
6
Geode Capital Management
Massachusetts
$924K +$892K +102,555 New
CS
7
Credit Suisse
Switzerland
$382K +$369K +42,450 New
MCM
8
Moore Capital Management
New York
$239K -$1.94M -223,500 -89%
Northern Trust
9
Northern Trust
Illinois
$169K +$163K +18,702 New
Verition Fund Management
10
Verition Fund Management
Connecticut
$132K -$59.1K -6,797 -32%
CLOS
11
Compagnie Lombard Odier SCmA
Switzerland
$95K +$91.4K +10,500 New
TRCT
12
Tower Research Capital (TRC)
New York
$10K +$3.76K +432 +66%
US Bancorp
13
US Bancorp
Minnesota
$9K +$8.7K +1,000 New
UBS Group
14
UBS Group
Switzerland
$7K -$6.2K -713 -47%
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
$7K – – –
S
16
SignatureFD
Georgia
$1K +$522 +60 New
Wells Fargo
17
Wells Fargo
California
$1K +$600 +69 New
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
– -$17.4M -1,750,000 Closed
Millennium Management
19
Millennium Management
New York
– -$14.8M -1,480,446 Closed
ACA
20
Arena Capital Advisors
California
– -$11.7M -1,171,480 Closed
SC
21
Sculptor Capital
New York
– -$11.1M -1,108,352 Closed
FTCM
22
First Trust Capital Management
Illinois
– -$8.38M -847,315 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
23
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
– -$8.11M -815,000 Closed
Marshall Wace
24
Marshall Wace
United Kingdom
– -$7.33M -736,968 Closed
Citadel Advisors
25
Citadel Advisors
Florida
– -$6.24M -627,066 Closed
1
2 3 4

PROK Hedge Fund Activity: Q3 2022 in Review

18 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ProKidney (PROK) for Q3 2022, worth a combined $144M — down 23% from $187M a quarter earlier.

Sellers outnumbered buyers: 60 funds closed out of PROK and 12 opened new positions — a net loss of 48 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $90.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $17.4M sold.

  • 18 institutional investors held ProKidney (PROK) as of Q3 2022, down from 67 in Q2 2022.
  • Funds reported $144M of ProKidney stock for Q3 2022, down 23% quarter-over-quarter.
  • 12 funds opened new ProKidney positions in Q3 2022 and 60 closed out, a net change of -48 holders.
  • The largest ProKidney buyer in Q3 2022 was Morgan Stanley, an estimated $90.1M added.
  • The largest ProKidney seller in Q3 2022 was Adage Capital Partners, an estimated $17.4M sold.

Based on aggregated 13F filings for Q3 2022.